38.20NOK-1.04%Mkt Cap: 55.20M $P/E: —1d ago
Gentian Diagnostics ASA develops, manufactures, and sells biochemical reagents for use in medical diagnostics and research in the United States, Asia, and Europe. It offers in-vitro diagnostic reagents for clinical chemi…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap55.20M $
Enterprise Value49.36M $
Revenue (TTM)17.02M $
Gross Profit9.18M $
Net Income (TTM)1.24M $
Revenue/Share1.103 USD
Last Price38.20 NOK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees63
CountryNO
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)14.81
PEG—
EV/EBITDA20.39
EV/Revenue2.90
P/S3.24
P/B3.23
EPS (TTM)-0.55
EPS (Forward)2.58
52W Range
33.5018% of range60.00
52W High60.00 NOK
52W Low33.50 NOK
Profitability
Gross Margin55.64%
Oper. Margin11.88%
EBITDA Margin14.22%
Profit Margin7.51%
ROE6.47%
ROA5.13%
Growth
Revenue Growth14.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF3.98M $
CapEx (TTM)1.01M $
FCF Margin0.79%
FCF Yield0.24%
Net Debt-5.85M $
Net Debt/EBITDA-2.41
Balance Sheet
Debt/Equity0.11
Current Ratio7.43
Quick Ratio5.20
Book Value/Sh11.82 NOK
Cash/Share5.132 NOK
Dividends
Fwd Div Rate0.6000 NOK
Trail. Div Rate0.6000 NOK
Div. Yield1.55%
5Y Avg Yield—
Payout Ratio46.51%
Ex-Div DateMay 6, 2026
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)60.00 NOK
Upside (mean)+57.1%
Target Range60.00 NOK – 60.00 NOK
# Analysts1
Ownership
Shares Out.15.46M
Float11.69M
Insiders44.62%
Institutions39.98%
Technical
SMA 5037.26 (+2.5%)
SMA 20046.98 (-18.7%)
Beta0.45
S&P 52W Chg19.63%
Avg Vol (30d)3.77K
Avg Vol (10d)3.45K
Technical Indicators
RSI (14)52.4
MACD0.3534
MACD Signal0.1754
MACD Hist.+0.1780
BB Upper40.38 NOK
BB Middle37.28 NOK
BB Lower34.19 NOK
BB Width16.61%
ATR (14)1.983 NOK
Vol Ratio (20d)0.05x